Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

clinical trialsClinicalTrials.govT1Dtrial matching

What this is and is not

This is a discovery layer for official trial records. It is not an eligibility decision, treatment recommendation, or invitation to share private health information.

A useful trial watch should help a family ask better questions: Who is eligible? What is the intervention? Where is the site? What is the burden? What endpoints are being measured?

Recruiting records to inspect

Simultaneous Measurement and Responsive Treatment - Part 2 — RECRUITING, EARLY_PHASE1. Interventions: DPP System (Insulin Pump and Continuous Glucose Monitoring Platform). Locations: Toronto, Ontario, Canada. This research study is testing an investigational dual-port insulin pat...Source
Bioavailability, Biopotency and Food Effect Study of SCD0503 Compared to Subcutaneous Regular Human Insulin — RECRUITING, PHASE1. Interventions: oral insulin, Placebo A, subcutaneous insulin. Locations: Neuss, North Rhine-Westphalia, Germany. Reason for the study The participants have been diagnosed with type 1 diabetes and are...Source
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes — RECRUITING, PHASE2. Interventions: High Dose SAB-142, Low Dose SAB-142, Placebo. Locations: San Francisco, California, United States | San Jose, California, United States | Aurora, Colorado, United States. This is a Pha...Source
The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action — RECRUITING, PHASE2. Interventions: Metformin. Locations: Indianapolis, Indiana, United States. Ovwerweight and obesity prevalence in persons with T1D has increased, which further complicates management and risk for comp...Source
Family Intervention for Black Teens With Type 1 Diabetes — RECRUITING, NA. Interventions: The 3Ms 2.0 Intervention, Educational Attention Control (EAC). Locations: Washington D.C., District of Columbia, United States | Detroit, Michigan, United States | Memphis, Tennessee, Unit...Source
Monocytes in Subjects With Type 1 Diabetes and Chronic Kidney Disease — RECRUITING. Locations: Cleveland, Ohio, United States. This is a cross-sectional study in patients with Type 1 diabetes (TID) and chronic kidney disease (CKD) to test if time in range (TIR) affects the degree of hypergl...Source

Questions before contacting a study

Is the study specifically for Type 1 diabetes, and does it match the participant age, disease stage, and treatment context?
What travel, visit frequency, labs, devices, medication changes, and hypoglycemia risk are involved?
Can the family discuss the official record with their endocrinology team before sharing additional personal health details?

This article is an evidence-labeled information brief, not medical advice. Use the linked source records and your care team before making treatment decisions.